DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway

JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
Jinrun Wang, Yang Liu, Yanze Li +3
Scientific Reports21 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
URGCP promotes osteosarcoma progression by regulating the ESCRT-III subunit CHMP4B
Yue Wang, Yuhuai Wu, Bin Zhou +1
Translational cancer research20 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
CGRP remodels the acidic microenvironment and promotes pancreatic carcinoma progression by regulating NHE1 and CA9
Sa Liu, Shanshan Wei, Taoli Sun +5
Frontiers in pharmacology1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCCrossref
AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway
Translational cancer research28 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2
Chang‐Cheng Liu, Xue‐Dong Li
Kaohsiung Journal of Medical Sciences6 Nov 2026Peer-reviewedCC BYFull textGeneral medicineDOAJ

Cite

BibTeX

@article{anon2026dusp13,
  title = {{DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway}},
  journal = {Translational andrology and urology},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13657761},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
PY  - 2026
DA  - 2026/08/31
JO  - Translational andrology and urology
UR  - https://europepmc.org/article/PMC/PMC13657761
SN  - 2223-4691
ER  -

Related

Cite